Francais (Fr)English (United Kingdom)
Recherche
Actualités

Francis Lévi, Warwick Medical School, University of Warwick, July 21, 2014:

- Circadian control of xenobiotic carcinogenesis and cancer pharmacology

- Toward Systems Cancer Chronotherapeutics and its integration into home care 

La Société Francophone de Chronobiologie (SFC) organise son 44ème congrès qui se déroulera du 29-31 octobre 2014

Séance de la Société de Biologie " La chronobiologie " aura lieu le 15 octobre 2014 de 15h00 à 18h00 Institut Curie-Pavillon Curie Amphithéâtre Marie Curie 11, rue Pierre et Marie Curie – Paris 5ème

La soutenance de thèse de Melle Véronique ROCHE sera présentée le 21 mai 2014

Reportage BBC, 13 mai 2014  Chronotherapy: The science of timing drugs to our Body

Journal "Le monde" le 30 avril 2014, "Quand l'horloge biologique se détraque"

 

Voir la suite

Contact

UMRS 935

Equipe3 : Chronothérapie des cancers

et optimisation de la fonction hépatique

INSERM et Université Paris Sud

Bât A 3ème étage Campus CNRS
7 rue Guy Môquet
94801 Villejuif Cedex (France)
Tel :  +33 (0) 1 49 58 34 83
Fax : +33 (0) 1 49 58 34 59
Email:gladys.germe@inserm.fr

Home Production scientifique Publication

2004

 Lévi F. : Gènes de l’horloge : rythmes circadiens et cancers. 6ème Biennale Monégasque de Cancérologie, Monte-Carlo, Principauté de Monaco, 28-31 Janvier 2004. (Invité)

 Giacchetti S., Lévi F.: La chronothérapie dans les cancers digestifs. 6ème Biennale Monégasque de Cancérologie, Monte-Carlo, Principauté de Monaco, 28-31 Janvier 2004. (Invité)

 Lévi F., Filipski E., Innominato P., Wu M.W., Li X.M., Delaunay F., Hastings M. : Relevance of circadian clock function for cancer processes. 2nd International Symposium on Molecular Clock : Molecular Clock Tokyo 2004, Tokyo, Japon, February 26-28th 2004. (Invité)

 Li X.M., Kanekal S., Crépin D., Filipski M., Crain B., Guettier C., Elliott G., Leoni L., Lévi F. : Circadian dosing of SDX-102 (L-alanosine) decreases toxicity in mice without diminishing efficacy. Proc. American Association for Cancer Research 95th Annual Meeting, March 27-31st 2004, Orlando, Florida, U.S.A., 2004, 45 : abstr. # 2098.

 Lévi F. : Biological rhythms and cancer processes. 3rd Postgraduate Educational Course on Chronobiology and Chronomedicine, Medical Chronobiology and its Applications, Society for Chronobiology, April 16-18th 2004, Urgüp, Cappadocia, Turkey. (Invité)

 Lévi F. : Cancer chronotherapeutics. 3rd Postgraduate Educational Course on Chronobiology and Chronomedicine, Medical Chronobiology and its Applications, Society for Chronobiology, April 16-18th 2004, Urgüp, Cappadocia, Turkey. (Invité)

 Basdevant C., Clairambault J., Lévi F. : Stratégies d’injection optimales en chronothérapie du cancer. 36ème Congrès de la Société Francophone de Chronobiologie, Rennes, 17-19 Mai 2004.

 Lévi F., Filipski E., Innominato P., Wu M.W., Li X.M., Delaunay F., Claustrat B., Hastings M. : Interactions entre horloge circadienne et processus cancéreux. 36ème Congrès de la Société Francophone de Chronobiologie, Rennes, 17-19 Mai 2004.

 Lévi F. A., Tubiana-Mathieu N., Focan C., Brézault-Bonnet C., Coudert B., Carvalho C., Genet D., Giacchetti S., Lentz M., Baron B. : Chronomodulated (Chrono) vs constant (Cst) rate infusional 5-fluorouracil (FU) with or without cisplatin (CDDP) in patients with advanced or metastatic pancreatic cancer. A multicenter randomized trial of the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer (EORTC 05962). Proc. American Society of Clinical Oncology, 40th Annual Meeting, June 5-8th 2004, New-Orleans, U.S.A., 2004, 23 : 341 (abstr. 4117).

 Giacchetti S., Bjarnason G., Garufi C., Tubiana-Mathieu N., Iacobelli S., Dogliotti L., Smaaland R., Focan C., Coudert B., Lévi F. : First line infusion of 5-Fluorouracil, Leucovorin and Oxaliplatin for metastatic colorectal cancer : 4-day chronomodulated (FFL4-10) versus 2-day FOLFOX2. A multicenter randomized Phase III trial of the Chronotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC 05963). Proc. American Society of Clinical Oncology, 40th Annual Meeting, June 5-8th 2004, New-Orleans, U.S.A., 2004, 23 : 252 (abstr. 3526).

 Bouchahda M., Tanaka K., Adam R., Giacchetti S., Brézault-Bonnet C., Gholam D., Kunstlinger F., Castaing D., Jasmin C., Lévi F.A. : Hepatic artery chronomodulated infusion of irinotecan, 5-fluorouracil and oxaliplatin against liver metastases in heavily-pretreated patients with colorectal cancer. Proc. American Society of Clinical Oncology, 40th Annual Meeting, June 5-8th 2004, New-Orleans, U.S.A., 2004, 23 : 300 (abstr. 3722).

 Innominato P.F., Rich T., Boerner J., Mormont M.C., Iacobelli S., Jasmin C., Lévi F. High serum TGFa, TNFa and IL6 correlate with abnormal circadian rhythms in patients with metastatic colorectal cancer (MCC). Proc. American Society of Clinical Oncology, 40th Annual Meeting, June 5-8th 2004, New-Orleans, U.S.A., 2004, 23 : 868 (abstr. 9650).

 Gholam D., Giacchetti S., Brézault-Bonnet C., Bouchahda M., Sverdlin R., Adam R., Jasmin C., Lévi F. : Chronomodulated irinotecan (I), fluorouracil (F), leucovorin (L) and oxaliplatin (O) (chrono IFLO) as salvage therapy in oxaliplatin – and irinotecan-resistant advanced colorectal cancer (ACRC) : treatment results and toxicity profile. Proc. American Society of Clinical Oncology, 40th Annual Meeting, June 5-8th 2004, New-Orleans, U.S.A., 2004, 23 : 258 (abstr. 3551).

 Rich T., Innominato P., Mormont M.C., Boerner J., Iacobelli S., Jasmin C., Boran B., Lévi F. : Performance status, global quality of life, fatigue, and appetite loss are correlated with serum TGFa and IL-6 in patients with metastatic colorectal cancer (MCC). Proc. American Society of Clinical Oncology, 40th Annual Meeting, June 5-8th 2004, New-Orleans, U.S.A., 2004, 23 : 731 (abstr. 8024).

 Adam R., Delvart V., Pascal G., Castaing D., Azoulay D., Giacchetti S., Paule B., Lévi F., Kunstlinger F., Bismuth H. : Resection of non resectable liver metastases after chemotherapy : prognostic factors and long term results. Proc. American Society of Clinical Oncology, 40th Annual Meeting, June 5-8th 2004, New-Orleans, U.S.A., 2004, 23 : 258 (abstr. 3550).

 Innominato P., Filipski E., Li X.M., Lévi F. : Effects of experimental chronic jet-lag on clock and cell cycle gene expression. Proc. Nineth Meeting Society for Research on Biological Rhythms, June 24-26 2004, Whistler (Vancouver), British Colombia, Canada, 2004 : abstr.229.

 Lévi F. : Implications of biological clocks for cancer processes and their treatments. 34th Annual Meeting of the European Environmental Mutagen Society (EEMS 2004), Maastricht, The Netherlands, September 4-8th 2004. (Invité)

 Lévi F. : Activity of chronotherapy. 3rd International Symposium about “Controversies in liver tumors”, Pordenone, Italie, September 17th 2004. (Invité)

 Filipski E., Filipski M., Georgsson H., Gianella-Borradori A., Lévi F. : Cyclin-dependent kinase (CDK) inhibitor CYC202 (R-roscovitine) induces clock gene mPer2 mRNA expression rhythm in tumor : relevance for antitumor efficacy. 16th EORTC-NCI-AACR Symposium, Geneva, Switzerland, September 28th – October 1st 2004.

 Lévi F. : Chronotherapy : the relevance of timing in the therapy of cancer. International Conference Cancer and Rhythm : a new challenge in occupational medicine, Graz, Austria, October 14-16th 2004. (Invité)

 Filipski E. : Disruption of circadian coordination and malignant growth. International Conference Cancer and Rhythm : a new challenge in occupational medicine, Graz, Austria, October 14-16th 2004. (Invité)

 Smaaland R., Guettier C., Filipski E., Li X.M., Fujii Y., Clay D., Clairambault J., Carrière J., Lévi F. : Accelerated tumor growth in mice with disturbed circadian rhythm. International Conference Cancer and Rhythm : a new challenge in occupational medicine, Graz, Austria, October 14-16th 2004.

 Lévi F. : Gènes de l’horloge, rythme circadien et cancer. 6ème Biennale Monégasque de Cancérologie, Monaco, 28-31 Janvier 2004. (Invité)

 Bouchahda  M., Tanaka K., Adam R., Giacchetti S., Brézault-Bonnet C., Gholam D., Sverdlin R., Hauteville D., Kunstlinger F., Castaing D., Jasmin C., Lévi F. : Chimiothérapie intra-artérielle hépatique (CIAH) chronomodulée de rattrapage associant Irinotecan, 5-Fluorouracil et oxaliplatine chez les patients atteints de métastases hépatiques de cancer colo-rectal multitraités. XXIVème Forum de Cancérologie, Paris, 29Juin-1er Juillet 2004. (Communication orale)

 Lévi F. : Evaluation et incidence des processus chronobiologiques. XIXème Congrès Société Française de Recherche sur le Sommeil-Société de Pneumologie de Langue Française, Bordeaux, 21-23 Octobre 2004. (Invité)

 Lévi F., Saguez C. : Le patient, la médecine ambulatoire et les technologies. 37èmes Journées de Gériatrie d’Ivry. Groupe Hospitalier Pitié-Salpêtrière, Paris, 18-19 Novembre 2004. (Invité)

<-Retour

 

Mise à jour le : 22/04/2015

Copyright © 2011 ---.
All Rights Reserved